相关实验视频

Updated: May 23, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

质母细胞受指导的星细胞抑制瘤特异性T细胞免疫力

Camilo Faust Akl^1,2, Brian M Andersen^1,3, Zhaorong Li¹

¹Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

|May 21, 2025

概括

某些星球细胞通过TRAIL诱导T细胞死亡来抑制质母细胞的免疫反应. 使用工程病毒向这种IL-11- STAT3- TRAIL通路可能会改善质母细胞瘤治疗结果.

科学领域:

神经瘤学
癌症免疫学
星球细胞生物学

背景情况:

质母细胞瘤 (GBM) 是一种具有治疗效果不佳的侵袭性脑癌.
GBM中的瘤微环境具有免疫抑制作用,阻碍抗瘤免疫力.
星球细胞在GBM免疫反应中的作用在很大程度上仍未被探索.

研究的目的:

研究质母细胞瘤中星细胞介导的免疫调节.
确定星球细胞对质母细胞瘤免疫规避的机制.
探索针对天体细胞驱动免疫抑制的治疗策略.

主要方法:

临床和临床前质母细胞瘤样本的单细胞和大量RNA测序.
在体内基于CRISPR的复合免疫光和遗传乱.
使用小鼠和人类实验系统的体外研究.

主要成果:

通过TRAIL识别了一种诱导T细胞亡的天体细胞子集,限制了抗瘤免疫力.
瘤衍生的IL-11驱动星球细胞中依赖STAT3的TRAIL表达.
星细胞中的STAT3和TRAIL信号与质母细胞瘤患者的生存时间缩短相关.
在小鼠模型中,禁用星球细胞IL-11受体或TRAIL改善了存活率和免疫反应.
在临床前模型中,一种被设计为阻断TRAIL的瘤病毒增强了生存和免疫力.

结论:

由IL-11-STAT3信号驱动的星球细胞通过TRAIL诱导的T细胞亡抑制质母细胞免疫力.
用治疗性病毒准这种星球细胞介导的免疫逃避途径对质母细胞瘤治疗有希望.

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.